ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
IO
IUCT-Oncopole at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
IUCT-Oncopole takes part in 3 sessions at ESMO 2026 in Madrid. Its research explores drug combinations across esophageal, breast and soft-tissue cancers. It compares durvalumab plus chemoradiotherapy with chemoradiotherapy alone for locally advanced esophageal cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
IO IUCT-Oncopole Toulouse, France | |
Cancer care and research centre in Toulouse, France, bringing together the Institut Claudius Regaud Unicancer centre and Toulouse University Hospital's cancer teams. | Abstract Fri Oct 23 17:09–17:14 Poster Sat Oct 24 12:00–12:45 Poster Mon Oct 26 12:00–12:45 Safety and preliminary activity of MEDI5752, a bispecific anti–PD-1/CTLA-4 antibody, combined with SBRT of one lung metastasis in patients with metastatic STS Sarcoma, CNS, head & neck and rare cancers |
Find decision makers at IUCT-Oncopole
Tell us what you sell and we’ll find the people at IUCT-Oncopole most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction